Groundbreaking Trial Shows How Immunotherapy "Changes the Outlook" of Certain Cancers

A new immunotherapy drug that cured patients of rectal cancer is bringing worldwide attention to the benefits and potential of this promising field. National Cancer Institute-designated Cancer Centers like the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC) are leading the way in studying the immune regulation of malignant disease to develop novel diagnostic, preventive and treatment regimens.